Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
Ceramides and IL-6 have a role in immune–inflammatory responses and cardiovascular diseases, and are suggested to be involved in insulin and glucose metabolism. We sought to assess the associations of circulating levels of IL-6, TNF-α and high-sensitivity C reactive protein (hsCRP), which are inflammatory markers related to insulin resistance (IR), with the plasma lipid metabolites ceramides and diacylglycerols (DAG) in patients with CHD.
Cross-sectional analyses were carried out on data from 33 patients with CHD. Serum levels of the inflammatory markers and plasma lipid metabolites (lipidomics approach performed by ultra-performance liquid chromatography coupled to electrospray ionisation MS) were measured at the same time point as insulin resistance (IR) (HOMA-IR index).
Serum circulating levels of IL-6 were strongly correlated with plasma ceramide concentrations (r = 0.59, p < 0.001). Adjustments for serum TNF-α or hsCRP levels, smoking, BMI, age, sex or HOMA-IR did not change the results (p < 0.001). After adjustments for the effect of serum inflammatory markers (TNF-α or hsCRP), HOMA-IR and BMI the correlation between plasma DAG and serum IL-6 (r = 0.33) was also significant (p < 0.03). In a linear regression model, circulating levels of both ceramides and TNF-α had a significant independent influence on circulating levels of IL-6, altogether accounting for 41% of its variation (p < 0.001).
Our results strongly suggest that the link between ceramides, IR and inflammation is related to the inflammatory marker IL-6. Ceramides may contribute to the induction of inflammation involved in IR states that frequently coexist with CHD.
The study was supported by the Finnish Cultural Foundation, the North-Savo Regional Fund of the Finnish Cultural Foundation, the Yrjö Jahnsson Foundation, the Sigrid Juselius Foundation, the Juho Vainio Foundation, the Kuopio University Hospital (grant 510RA07), the Academy of Finland (Projects 117844 and 118590) and by the Nordic Centre of Excellence on ‘Systems biology in controlled dietary interventions and cohort studies’ (SYSDIET), Project 070014.
- Summers, SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45: pp. 42-72 CrossRef
- Gaal, LF, Mertens, IL, Block, CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444: pp. 875-880 CrossRef
- Laaksonen, DE, Niskanen, L, Nyyssonen, K (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47: pp. 1403-1410 CrossRef
- Pradhan, AD, Ridker, PM (2002) Do atherosclerosis and type 2 diabetes share a common inflammatory basis?. Eur Heart J 23: pp. 831-834 CrossRef
- Holland, WL, Knotts, TA, Chavez, JA, Wang, LP, Hoehn, KL, Summers, SA (2007) Lipid mediators of insulin resistance. Nutr Rev 65: pp. S39-S46 CrossRef
- Bressler, P, Bailey, SR, Matsuda, M, DeFronzo, RA (1996) Insulin resistance and coronary artery disease. Diabetologia 39: pp. 1345-1350 CrossRef
- Erkkilä, AT, Schwab, US, Mello, VD (2008) Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. Eur J Nutr 47: pp. 319-328 CrossRef
- Lankinen, M, Schwab, US, Erkkilä, AT (2009) Fatty fish intake decreases lipids related to inflammation and insulin signaling—a lipidomics approach. PLoS ONE 4: pp. e5258 CrossRef
- Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: pp. 412-419 CrossRef
- Haus, JM, Kashyap, SR, Kasumov, T (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58: pp. 337-343 CrossRef
- Wu, D, Marko, M, Claycombe, K, Paulson, KE, Meydani, SN (2003) Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-κ B activity. J Biol Chem 278: pp. 10983-10992 CrossRef
- Vanden Berghe, W, Vermeulen, L, Wilde, G, Bosscher, K, Boone, E, Haegeman, G (2000) Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 60: pp. 1185-1195 CrossRef
- Yuan, M, Konstantopoulos, N, Lee, J (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293: pp. 1673-1677 CrossRef
- Devaraj, S, Venugopal, SK, Singh, U, Jialal, I (2005) Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α and -β. Diabetes 54: pp. 85-91 CrossRef
- Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
Volume 52, Issue 12 , pp 2612-2615
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Cardiovascular disease
- Insulin resistance
- Industry Sectors
- Author Affiliations
- 1. Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, P.O. Box 1627, Kuopio, Finland
- 2. VTT Technical Research Centre of Finland, Espoo, Finland
- 3. Department of Internal Medicine, Kuopio University Hospital, Kuopio, Finland
- 4. Department of Public Health, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland